Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Cell Type Identified in Cancer Development

14.03.2007
Scientists have discovered a new type of cell that appears to play a role in the development of cancer – a highly volatile, precancerous stem cell that can either remain benign or become malignant, depending upon environmental cues.

The finding may help define the role of cancer stem cells in the growth and recurrence of the disease as well as offer new options for cancer prevention, detection and treatment.

Current cancer stem cell theory holds that tumors are comprised of a variety of cell types. Among them is a small subset of rather primitive cells that, like other stem cells in the body, are self-sustaining, self-renewing and multipotent, or capable of creating other types of cells and tissues. These cells are different from normal stem cells, however, in that injecting even as few as 100 of them into laboratory animals will cause cancer. Scientists have dubbed these cancer stem cells.

Cancer stem cells were first identified in leukemia, but they have also been found in breast, brain, colon and prostate cancers. Because they are rather unstable, they are notoriously tricky to isolate and describe. They are also resistant to virtually any kind of treatment, and some scientists believe they are the reason cancer recurs.

... more about:
»Cancer »Gao »Ohio »immune system »malignant »pCSC »precancerous

Until now, no one has known how they arise.

But a team of scientists, led by Dr. Jian-Xin Gao, a researcher in the department of pathology at Ohio State University Medical Center, has identified a new set of cells he calls precancerous stem cells (pCSCs).

These cells share some of the characteristics full-fledged cancer stem cells have, but they are different in that they respond to distinct cell signals that determine their ultimate fate – whether they will continue to grow into cancer or cancer stem cells, lie inactive or be eradicated by the body’s immune system.

“These hybrid cells are very complex. They have properties of normal and abnormal stem cells, and do not always lead to cancer – only some of the time, and under very specific conditions,” says Gao, who is also a member of the Ohio State University Comprehensive Cancer Center. “These cells appear to be a whole new class of cells involved in the development of cancer.”

The study appears in the Wednesday, March 21 edition of PLoS ONE, the international, peer-reviewed, open-access, online publication from the Public Library of Science (PLoS).

The findings emerged from a study in which Gao and his colleagues were investigating tumor growth in mice. They discovered that some of the animals had lymphoma, and that several cell lines from those tumors carried a unique and provocative phenotype, or surface protein signature: They carried neither the Sca-1 or c-kit markers, hallmarks of normal bone marrow stem cells, nor the lineage markers most of the cancer cells had, but they did exhibit stem-like structure.

The researchers suspected these unusual cells might be precancerous stems cells and designed several tests and experiments to find out more about them.

They selected three pCSC lines and injected them subcutaneously, intraperitoneally or intravenously into three groups of mice. The mice represented different levels of immune function: One group was comprised of severe combined immune deficient mice, a second group was composed of mice whose immune systems had been knocked out by radiation, but had been partially restored by an infusion of bone marrow cells; and the third group was made up of normal, healthy mice.

The results showed that the strength of the immune system affected whether or not the mice got cancer. The scientists found that the pCSCs, like normal stem cells, had the ability to create various types of benign cells in mice with healthy or recovering immune systems. These daughter cells, however, were likely to die, especially when they encountered signals to further differentiate – a strong contrast to the behavior of normal stem cells.

“We thought this was an interesting development,” says Gao, “because these precancerous cells were actually stopped from becoming malignant. We are calling this process ‘differentiation-induced cell death,’ a protective mechanism the body may invoke to prevent pCSCs from maturing into full-blown cancer stem cells.”

It was a different story with the mice with impaired immune systems, however. In those animals, the pCSCs developed into solid tumors, developing additional mutations in different cell types as they grew and spread.

Additional experiments revealed that the piwil2 gene may exclusively regulate the process of pCSC development.

Gao says these data suggest some important characteristics of pCSCs.

“First, it appears that pCSCs require some sort of signal, or cue, from their immediate environment that directs them to become benign or malignant. Second, it seems clear that they can be detected and eliminated by a robust immune system when they are actively developing into cancer cells.”

Cancer stem cell theory is still in its infancy, but Gao feels these findings, if validated by additional studies, point to a candidate population of precancerous cells that may one day be a valuable target for new drugs and treatments. “To cure cancer, we have to eliminate all potential malignant cells – not just the ones within easy reach.”

The study received grant support from a number of sources, including the American Cancer Society, the National Cancer Institute, the U. S. Army Chronic Myelogenous Leukemia Research Program and the National Institute of Child and Human Development.

Colleagues contributing to the study include lead author Li Chen, Rulong Shen, Yin Ye, Ying Wang, Yan Liu, Larry Lasky, Nyla Heerema, Allen Yates and Sanford Barsky, all members of Ohio State’s Department of Pathology; Xingluo Liu, Wenrui Duan, Jing Wen, Jason Zimmerer, Danilo Perrotti and William Carson, from Ohio State’s Comprehensive Cancer Center; Xin-An Pu from OSU’s Center for Molecular Neurobiology; Haifan Lin, from Yale University; Keiko Ozato, from the National Institute of Child Health and Human Development; and Satomi Kuramochi-Miyagawa, and Toru Nakano from Osaka University, Japan.

Andrew Hyde | alfa
Further information:
http://www.plosone.org
http://dx.doi.org/10.1371/journal.pone.0000293

Further reports about: Cancer Gao Ohio immune system malignant pCSC precancerous

More articles from Life Sciences:

nachricht Scientists unlock ability to generate new sensory hair cells
22.02.2017 | Brigham and Women's Hospital

nachricht New insights into the information processing of motor neurons
22.02.2017 | Max Planck Florida Institute for Neuroscience

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Microhotplates for a smart gas sensor

22.02.2017 | Power and Electrical Engineering

Scientists unlock ability to generate new sensory hair cells

22.02.2017 | Life Sciences

Prediction: More gas-giants will be found orbiting Sun-like stars

22.02.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>